學術研究成果/Publication
|
基本資料/Profiles
|
姓名/Name: |
簡君儒
|
性別/Gender: |
男
|
英文姓名/ English Name: |
Chien, Chun-Ru
|
英文縮寫/ Abbreviation: |
|
任職單位/ Affiliation: |
1.醫學院醫學系學士班放射腫瘤學科(教授) / Department of Radiation Oncology (Professor) 2.中國附醫放射腫瘤部粒子放射治療科(科(室)主任) / (Director)
|
Email: |
d16181@mail.cmu.edu.tw
|
研究專長/Fields of Specialty
|
1﹒ |
Radiation Oncology
|
2﹒ |
Comparative effectiveness research
|
|
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
|
SCI論文 |
涂智彥(Chih-Yen Tu)、夏德椿(Te-Chun Hsia)、林膺峻(Lin,Ying-Chun)、梁基安(Ji-An Liang)、李佳瑾、簡君儒(Chien, Chun-Ru)*,Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors,Canadian Respiratory Journal,2024 Mar,2024():8889536-8889536
|
SCI論文 |
柯道維(Tao-Wei Ke)、張伸吉(Sheng-Chi Chang)、廖裕民(Yu-Min Liao)、林哲弘(Che-Hung Lin)、陳自諒(Tzu-Liang Chen)、梁基安(Ji-An Liang)、李佳瑾(CHIA-CHIN LI)、簡君儒(Chien, Chun-Ru)*,Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study,ANTICANCER RESEARCH,2023 Dec,43(12):5713-5722
|
SCI論文 |
柯道維(Tao-Wei Ke)、張伸吉(Sheng-Chi Chang)、陳宏彰(Hung-Chang Chen)、王輝明(Hwei-Ming Wang)、陳自諒(Tzu-Liang Chen)、陳奕彰(Yi-Chang Chen)、謝明皓(Ming-Hao Hsieh)、蔡元耀(Yuan-Yao Tsai)、黃晟瑋(HUANG CHENG-WEI)、廖裕民(Yu-Min Liao)、林哲弘(Che-Hung Lin)、黃駿麟(Chun-Lin Huang)、陳良琦(Liang-Chi Chen)、簡君儒(Chien, Chun-Ru)*,Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort Study,ANTICANCER RESEARCH,2023 Apr,43(4):1843-1851
|
SCI論文 |
李佳瑾(Chia-Chin Li)、林膺峻(Lin,Ying-Chun)、梁基安(Ji-An Liang)、趙坤山(Kun-San Clifford Chao)、夏德椿(Te-Chun Hsia)、簡君儒(Chien, Chun-Ru)*,Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review,International Journal of Environmental Research and Public Health,2023 Mar,20():4727
|
SCI論文 |
(Chia-Chin Li)、(Chih-Yi Chen)、(Ying-Hsiang Chou)、(Chih-Jen Huang)、(Hsiu-Ying Ku)、林膺峻(Lin,Ying-Chun)、簡君儒(Chien, Chun-Ru)*,High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: an endemic area population-based study,Discover Oncology,2022 Nov,13(1):130
|
SCI論文 |
林振源(Chen-Yuan,Lin)、連銘渝(Ming-Yu Lien)、陳其敬(Chi-Ching Chen)、方信元(Hsin-Yuan Fang)、林昱森(Yu-Sen Lin)、陳建光(Chien-Kuang Chen)、陳建勳(Jian-Xun Chen)、呂庭聿(Ting-Yu Lu)、黃子旻(Tzu-Min Huang)、謝德鈞(Te-Chun Hsieh)、孫盛生(Shung-Shung Sun)、李佳瑾、簡君儒(Chien, Chun-Ru)*,Consolidative chemotherapy after defnitive concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients: a population based cohort study,BMC GASTROENTEROLOGY,2022 Aug,22(1):381
|
SCI論文 |
葉士芃(Shih-Peng Yeh)、林宏霖(Hung-Lin Lin)、簡君儒(Chien, Chun-Ru)*,Long term survival of Enteropathy-associated T-cell Lymphoma (EATL) with intracranial metastasis: letter to the Editor,ACTA GASTRO-ENTEROLOGICA BELGICA,2022 Jul,85(3):535-536
|
SCI論文 |
涂智彥(Chih-Yen Tu)、陳鴻仁(Hung-Jen Chen)、夏德椿(Te-Chun Hsia)、方信元(Hsin-Yuan Fang)、李佳瑾、簡君儒(Chien, Chun-Ru)*,Adjuvant Concurrent Chemoradiotherapy Versus Adjuvant Chemotherapy Only in Locally Advanced Non-small-cell Lung Cancer With Involved Microscopic Resection Margin: A Population-based Cohort Study,ANTICANCER RESEARCH,2022 Jun,42(6):3195-3201
|
SCI論文 |
方信元(Hsin-Yuan Fang)、林昱森(Yu-Sen Lin)、陳建光(Chien-Kuang Chen)、陳建勳(Jian-Xun Chen)、呂庭聿(Ting-Yu Lu)、黃子旻(Tzu-Min Huang)、謝德鈞(Te-Chun Hsieh)、郭于誠(Yu-Cheng Kuo)、林振源(Chen-Yuan,Lin)、連銘渝(Ming-Yu Lien)、陳其敬(Chi-Ching Chen)、李佳瑾、簡君儒(Chien, Chun-Ru)*,Effectiveness evaluation of adjuvant concurrent chemoradiotherapy for patients with positron emission tomography-staged esophageal squamous cell carcinoma after complete resection: A population-based cohort study,Thoracic Cancer,2022 May,XX(XX):XX-XX
|
SCI論文 |
鄭文建(Wen-Chien Cheng)、沈宜成(Yi-Cheng Shen)、簡君儒(Chien, Chun-Ru)、廖偉志(Wei-Chih Liao)、陳家弘(Chia-Hung Chen)、夏德椿(Te-Chun Hsia)、涂智彥(Chih-Yen Tu)、陳鴻仁(Hung-Jen Chen)*,The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from Taiwan,Thoracic Cancer,2022 Mar,2022():
|
SCI論文 |
梁基安(Liang, Ji-An)、郭于誠(Yu-Cheng Kuo)、趙坤山(Kun-San Clifford Chao)、陳自諒(Tzu-Liang Chen)、柯道維(Tao-Wei Ke)、周思賢(Szu-Hsien Chou)、李佳瑾、簡君儒(Chien, Chun-Ru)*,High vs. Standard Radiotherapy Dose in Locally Advanced Rectal Adenocarcinoma Patients Treated With Neoadjuvant Long Course Chemoradiotherapy: A Population-based Study,ANTICANCER RESEARCH,2022 Feb,42(2):1143-1150
|
Other論文 |
林圀宏(Kuo-Hung Lin)、徐華穗(Hua-Shai Hsu)、馮俊龍(Chun-Lung Feng)、高嘉鴻(Chia-Hung Kao)、周思賢(Szu-Hsien Chou)、梁基安(Liang, Ji-An)、簡君儒(Chien, Chun-Ru)*,Cardiovascular implantable electronic devices may tolerate high dose radiotherapy: an updated case report with long term follow-up,Therapeutic Radiology and Oncology,2021 Dec,5():18
|
SCI論文 |
李佳瑾、(Chen Chih-Yi)、(Chou Ying-Hsiang)、(Huang Chih-Jen)、(Ku Hsiu-Ying)、簡君儒(Chun-Ru Chien)*,Optimal Radiotherapy Dose in Cervical Esophagus Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy: a Population Based Study,Thoracic Cancer,2021 Jul,12(14):2065-2071
|
SCI論文 |
(I-Han Lee)、(Guann-Yiing Chen)、簡君儒(Chun-Ru Chien)、(Jason Chia-Hsien Cheng)、(Jenny Ling-Yu Chen)、(Wen-Chi Yang)、(Jin-Shing Chen)、(Feng-Ming Hsu)*,A retrospective study of clinicopathologic and molecular features of inoperable early stage non-small cell lung cancer treated with stereotactic ablative radiotherapy,JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,2021 Jul,XX(XX):XX-XX
|
SCI論文 |
(Chia?Chin Li)、(Chih?Yi Chen)、(Ying?Hsiang Chou)、(Chih?Jen Huang)、(Hsiu?Ying Ku)、簡君儒(Chun-Ru Chien)*,Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b : a population‑based study,BMC GASTROENTEROLOGY,2021 Apr,21(1):153
|
SCI論文 |
梁基安(Ji-An Liang)、李博彰(LEE PO-CHANG)、古君平(KU CHUN-PING)、陳自諒(Tzu-Liang Chen)、郭于誠(Yu-Cheng Kuo)、周思賢(Szu-Hsien Chou)、(Chia-Chin Li)、簡君儒(Chun-Ru Chien)*,Effectiveness of Image-Guided Radiotherapy in Adjuvant Radiotherapy on Survival for Localized Breast Cancer: A Population-Based Analysis,Cancer Management and Research,2021 Apr,13():3465-3472
|
SCI論文 |
(YAO-HUNG KUO)、梁基安(Ji-An Liang)、陳冠亨(Guang-Heng Chen)、李佳瑾、簡君儒(Chun-Ru Chien)*,Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis,BRITISH JOURNAL OF RADIOLOGY,2021 Mar,94(XX):XX-XX
|
SCI論文 |
陳鴻仁(Hung-Jen Chen)*、涂智彥(Chih-Yen Tu)、黃國揚(Kuo-Yang Huang)、簡君儒(Chun-Ru Chien)、夏德椿(Te-Chun Hsia),Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma,PLoS One,2020 Dec,15(12):e0240736
|
SCI論文 |
陳鴻仁(Hung-Jen Chen)、涂智彥(Chih-Yen Tu)、夏德椿(Te-Chun Hsia)、方信元(Hsin-Yuan Fang)、陳家弘(Chia-Hung Chen)、陳碩爵(Shuo-Chueh Chen)、李嘉翔(Chia-Hsiang Li)、廖裕民(Yu-Min Liao)、謝清昀(Ching-Yun Hsieh)、連銘渝(Ming-Yu Lien)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)*,Prognostic Significance of Oligometastatic Disease Classification by the ESTRO/EORTC of Cancer for Patients With Lung Cancer Treated With Definitive Radical Radiotherapy,ANTICANCER RESEARCH,2020 Oct,40(10):5895-5899
|
SCI論文 |
陳鴻仁(Hung-Jen Chen)、陳家弘(Chia-Hung Chen)、陳碩爵(Shuo-Chueh Chen)、林宏霖(Hung-Lin Lin)、夏德椿(Te-Chun Hsia)、涂智彥(Chih-Yen Tu)、杭良文(Liang-Wen Hang)、鄭文建(Wen-Chien Cheng)、李佳瑾、簡君儒(Chun-Ru Chien)*,Focal conformal fractionated radiotherapy vs. radiosurgery for lung cancer patients with limited brain metastases,Annals of Palliative Medicine,2020 Sep,9(5):2600-2605
|
SCI論文 |
梁基安(Ji-An Liang)、涂智彥(Chih-Yen Tu)、夏德椿(Te-Chun Hsia)、方信元(Hsin-Yuan Fang)、李佳瑾(Chia-Chin Li)、簡君儒(Chun-Ru Chien)*,Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy,Thoracic Cancer,2020 Jul,11(9):2639-2649
|
SCI論文 |
張鳳媛(Fang-Yuan Chang)、簡君儒(Chun-Ru Chien)*,The importance of out-of-pocket cost information in the era of financial toxicity of cancer care,SUPPORTIVE CARE IN CANCER,2020 May,XX():
|
Other論文 |
林亭君(Ting-Chun Lin)、方信元(Hsin-Yuan Fang)、謝清昀(Ching-Yun Hsieh)、徐新政(Hsin-Cheng Hsu)、高嘉鴻(Chia-Hung Kao)、楊仕哲(Su-Tso Yang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)*,Abscopal effect of unirradiated lung nodules following radiotherapy alone in recurrent non-small cell lung cancer: a case report,放射治療與腫瘤學,2020 May,19(111):1-6
|
SCI論文 |
梁信杰(Shinn-Jye Liang)、簡君儒(Chun-Ru Chien)*,Regarding Kaanders JHAM et al. “Advances in cancer imaging require renewed radiotherapy dose and target volume concepts”,RADIOTHERAPY AND ONCOLOGY,2020 May,S0167-8140(20):30296-30296
|
SCI論文 |
林振源(Lin, Chen-Yuan)、方信元(Hsin-Yuan Fang)、連銘渝(Ming-Yu Lien)、林精湛(Ching-Chan Lin)、白禮源(Li-Yuan Bai)、蔡明宏(Ming-Hung Tsai)、陳其敬(Chi-Ching Chen)、謝德鈞(Te-Chun Hsieh)、王耀慶(Yao-Ching Wang)、梁基安(Ji-An Liang)、李佳瑾(Chia-Chin Li)、簡君儒(Chun-Ru Chien)*,Clinical Outcomes and Prognostic Factors of Patients with Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated with Radical Re-irradiation,ANTICANCER RESEARCH,2020 Apr,40(4):2387-2392
|
SCI論文 |
郭躍虹(Yao-Hung Kuo)、方信元(Hsin-Yuan Fang)、林昱森(Yu-Sen Lin)、連銘渝(Ming-Yu Lein)、楊其穎(Chi-Ying Yang)、何士奇(HO SHIH-CHI)、李佳瑾、簡君儒(Chun-Ru Chien)*,Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy,Thoracic Cancer,2020 Jan,11(1):113-119
|
SCI論文 |
郭躍虹(Yao-Hung Kuo)、簡玉雯(Yu-Wen Chien)、陳品儒(Pin-Ru Chen)、馮俊龍(Chun-Lung Feng)、李佳瑾、簡君儒(Chun-Ru Chien)*,Impact of the interval between neoadjuvant concurrent chemoradiotherapy and esophagectomy in the modern era: a population-based propensity-score-matched retrospective cohort study in Asia,World Journal of Surgical Oncology,2019 Dec,17(1):222-222
|
SCI論文 |
郭躍虹(Yao-Hung Kuo)、梁基安(Ji-An Liang)、王堂權(Wang, Tang-Chuan)、阮春榮(JUAN CHUN-JUNG)、李佳瑾、簡君儒(Chun-Ru Chien)*,Comparative effectiveness of simultaneous integrated boost vs sequential intensity-modulated radiotherapy for oropharyngeal or hypopharyngeal cancer patients: A population-based propensity score-matched analysis,MEDICINE,2019 Dec,98(51):e18474-e18474
|
SCI論文 |
(Ya Chen Tina Shih)*、(Ying Xu)、簡君儒(Chun-Ru Chien)、(Bumyang Kim)、(Yu Shen)、(Liang Li)、(Daniel M. Geynisman),Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data,PHARMACOECONOMICS,2019 Dec,37(12):1495-1507
|
SCI論文 |
徐華穗(Hua-Shai Hsu)、胡松林(Sung-Lin Hu)、簡君儒(Chun-Ru Chien)*,A Prognostic Score for Brain Metastases of Non‑small‑cell Lung Cancer in the Era of Precision Medicine,LUNG,2019 Oct,197(5):683-683
|
SCI論文 |
李佳瑾、梁基安(Ji-An Liang)、陳自諒(Tzu-Liang Chen)、簡君儒(Chun-Ru Chien)*,Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis,Asia-Pacific Journal of Clinical Oncology,2019 Jun,15(5):e197-e203
|
SCI論文 |
吳偉榤(WU WEI-CHIEH)、張宜儒(Chang, Yi-Ru)、賴宥良(Yo-Liang Lai)、蕭安成(An-Cheng Shiau)*、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、郭于誠(Yu-Cheng Kuo)、陳尚文(Shang-Wen Chen)*,Impact of body-mass factors on setup displacement during pelvic irradiation in patients with lower abdominal cancer,Radiology and Oncology,2019 Apr,0017():
|
SCI論文 |
夏德椿(Te-Chun Hsia)、涂智彥(Chih-Yen Tu)、李佳瑾、簡君儒(Chun-Ru Chien)*,In response to Komiya T et al. ‘‘Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database”,RADIOTHERAPY AND ONCOLOGY,2019 Apr,135(2019):199-199
|
SCI論文 |
李佳瑾、梁基安(Ji-An Liang)、鍾智淵(JHUANG JHIH-YUAN)、陳自諒(Tzu-Liang Chen)、簡君儒(Chun-Ru Chien)*,Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis,ANTICANCER RESEARCH,2019 Mar,39(3):1479-1484
|
SCI論文 |
李佳瑾、方信元(Hsin-Yuan Fang)、林振源(Chen-Yuan Lin)、沈偉誌(Wei-Chih Shen)、簡君儒(Chun-Ru Chien)*,Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose,ANTICANCER RESEARCH,2019 Jan,39(1):511-517
|
SCI論文 |
夏德椿(Te-Chun Hsia)、梁基安(Ji-An Liang)、李佳瑾、簡君儒(Chun-Ru Chien)*,Comparative effectiveness of concurrent chemoradiotherapy versus EGFR-tyrosine kinase inhibitors for the treatment of clinical stage IIIb lung adenocarcinoma patients with mutant EGFR,Thoracic Cancer,2018 Nov,9(11):1398-1405
|
SCI論文 |
簡君儒(Chun-Ru Chien)、(Daniel M. Geynisman)、(Bumyang Kim)、(Ying Xu)、(Ya-Chen Tina Shih)*,Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review,PHARMACOECONOMICS,2018 Nov,37(3):301-331
|
SCI論文 |
陳志毅(Chih-Yi Chen)、李佳瑾(Chia-Chin Li)、簡君儒(Chun-Ru Chien)*,Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients,World Journal of Surgical Oncology,2018 Jul,16(1):141-141
|
SCI論文 |
李佳瑾、陳志毅(Chih-Yi Chen)、簡君儒(Chien, Chun-Ru)*,Comparison of intensity-modulated radiotherapy vs 3-dimensional conformal radiotherapy for patients with non-metastatic esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy,MEDICINE,2018 Jun,97(22):e10928
|
SCI論文 |
涂智彥(Chih-Yen Tu)、夏德椿(Te-Chun Hsia)、方信元(Hsin-Yuan Fang)、梁基安(Ji-An Liang)、楊仕哲(Su-Tso Yang)、李佳瑾(Chia-Chin Li)、簡君儒(Chun-Ru Chien)*,A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients,Radiology and Oncology,2018 Jun,52(2):181-188
|
SCI論文 |
王耀慶(Yao-Ching Wang)、李佳瑾、簡君儒(Chun-Ru Chien)*,Effectiveness of tomotherapy vs linear accelerator image-guided intensity-modulated radiotherapy for localized pharyngeal cancer treated with definitive concurrent chemoradiotherapy: a Taiwanese population-based propensity score-matched analysis,BRITISH JOURNAL OF RADIOLOGY,2018 Jun,91(1086):20170947-XX
|
SCI論文 |
(Tsun-Jen Wen)、(Yu-Wen Wen)、簡君儒(Chien, Chun-Ru)、(Shao-Chin Chiang)、(William Wei-Yuan Hsu)、(Li-Jiuan Shen)、(Fei-Yuan Hsiao)*,Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin's lymphoma patients under Taiwan's national health insurance system,JOURNAL OF EVALUATION IN CLINICAL PRACTICE,2017 Apr,23(2):288-293
|
SCI論文 |
陳鴻仁(Hung-Jen Chen)、梁基安(Ji-An Liang)、陳志毅(Chih-Yi Chen)、余養豪(Yang-Hao Yu)、簡君儒(Chun-Ru Chien)*,What if a tumor is significantly enlarged just before stereotactic body radiation therapy? A case report and review of the literature,Thoracic Cancer,2017 Mar,8(2):118-120
|
SCI論文 |
(Ya-Chen Tina Shih)*、簡君儒(Chun-Ru Chien),A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment,CANCER,2017 Mar,123(6):928-939
|
SCI論文 |
李芃逸(Peng-Yi Lee)、林智遠(Chih-Yuan Lin)、陳尚文(Shang-Wen Chen)、簡君儒(Chun-Ru Chien)、朱俊男(Chu, Chin-Nan)、許琇婷(Hsiu-Ting Hsu)、梁基安(Ji-An Liang)、林膺峻(Ying-Chun Lin)、蕭安成(An-Cheng Shiau)*,A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy,Radiation Oncology,2017 Mar,12(55):1-9
|
SCI論文 |
簡君儒(Chun-Ru Chien)*、陳自諒(William Tzu-Liang Chen)、王輝明(Hwei-Ming Wang)、柯道維(TAO-WEI KE)、江驊哲(Hua-Che Chiang)、張伸吉(Sheng-Chi Chang)、黃郁純(YU-CHUEN HUANG)、林哲弘(Che-Hung Lin)、黃駿麟、林膺峻(Ying-Chun Lin)、陳宗偉(Tsung-Wei Chen)、李佳瑾、趙坤山(Kun-San Chao),A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer,ANTICANCER RESEARCH,2016 Nov,36(11):6155-6160
|
SCI論文 |
簡君儒(Chun-Ru Chien)、陳鴻仁(Hung-Jen Chen)*,Lazarus response to treatment of patients with lung cancer and oncogenic mutations in the intensive care unit,Journal of Thoracic Disease,2016 Nov,8(11):E1455-E1461
|
SCI論文 |
李佳瑾、陳志毅(Chih-Yi Chen)、簡君儒(Chun-Ru Chien)*,Comparative effectiveness of image-guided radiotherapy for non-operated localized esophageal squamous cell carcinoma patients receiving concurrent chemoradiotherapy: A population-based propensity score matched analysis,Oncotarget,2016 Sep,():
|
SCI論文 |
陳志毅(Chih-Yi Chen)、李佳瑾、簡君儒(Chun-Ru Chien)*,Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis,RADIOTHERAPY AND ONCOLOGY,2016 Jul,120(1):136-139
|
SCI論文 |
柯道維(TAO-WEI KE)、廖裕民(Yu-Min Liao)、江驊哲(Hua-Che Chiang)、張伸吉(Sheng-Chi Chang)、王品惠(Pin-Hui WANG)、陳怡雅(Yi-Ya CHEN)、陳自諒(William Tzu-Liang Chen)、簡君儒(Chun-Ru Chien)*,Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II–III rectal cancer: A population-based study,Asia-Pacific Journal of Clinical Oncology,2016 Jun,12(2):E234-E240
|
SCI論文 |
簡君儒(Chun-Ru Chien)*、陳自諒(William Tzu-Liang Chen)、王輝明(Hwei-Ming Wang)、林哲弘(Che-Hung Lin)、李佳瑾,Intensity-Modulated Radiotherapy in Neoadjuvant Concurrent Chemoradiotherapy for Locally advanced Rectal Cancer,DISEASES OF THE COLON & RECTUM,2016 Jun,59(6):e401
|
Other論文 |
李芃逸(Peng-Yi Lee)、簡君儒(Chien, Chun-Ru)、陳自諒(Chen, William Tzu-Liang)、柯道維(TAO-WEI KE)、郭于誠(Yu-Cheng, Kuo)、張伸吉(Sheng-Chi Chang)、林膺峻(Ying-Chun Lin),Treatment outcomes of neoadjuvant CCRT in patients with locally advanced rectal cancer- A single institutional report,放射治療與腫瘤學,2016 Jun,23(2):85-97
|
SCI論文 |
林振源(Chen-Yuan Lin)、方信元(Hsin-Yuan Fang)、馮俊龍(Chun-Lung Feng)、李佳瑾、簡君儒(Chun-Ru Chien)*,Cost-effectiveness of neoadjuvant concurrent chemoradiotherapy versus esophagectomy for locally advanced esophageal squamous cell carcinoma: A population-based matched case-control study,Thoracic Cancer,2016 Apr,7(3):288-295
|
SCI論文 |
(Ya-Chen Tina Shih)*、簡君儒(Chun-Ru Chien)、(Rocio Moguel)、(Mike Hernandez)、(Richard A. Hajek)、(Lovell A. Jones),Cost-Effectiveness Analysis of a Capitated Patient Navigation Program for Medicare Beneficiaries with Lung Cancer,HEALTH SERVICES RESEARCH,2016 Apr,51(2):746-767
|
SCI論文 |
夏德椿(Te-Chun Hsia)、涂智彥(Chih-Yen Tu)、方信元(Hsin-Yuan Fang)、梁基安(Ji-An Liang)、李佳瑾(Chia-Chin Li)、簡君儒(Chun-Ru Chien)*,Cost and effectiveness of image-guided radiotherapy for nonoperated localized lung cancer: a population-based propensity score-matched analysis,Journal of Thoracic Disease,2015 Sep,7(9):1643-1649
|
SCI論文 |
陳尚文(Shang-Wen Chen)、謝德鈞(Te-Chun Hsieh)、顏國揚(Kuo-Yang Yen)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、簡君儒(Chun-Ru Chien)、梁基安(Ji-An Liang)、高嘉鴻(Chia-Hung Kao)*,Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.,LARYNGOSCOPE,2014 Dec,124(12):2732-2738
|
SCI論文 |
方信元(Hsin-Yuan Fang)、(Fei-Yuan Sharon Hsiao)、黃旭志(Hsu-Chih Huang)、林昱森(Yu-Sen Lin)、(Chih-Yi Chen)、謝淑惠(Shwn-Huey Shieh)、陳品儒(Pin-Ru Chen)、陳建光(Chien-Kuang Chen)、簡君儒(Chun-Ru Chien)*,Cost and Effectiveness of Video-Assisted Thoracoscopic Surgery for Clinical Stage I Non-Small Cell Lung Cancer: a Population-based Analysis,Journal of Thoracic Disease,2014 Dec,6(12):1690-1696
|
SCI論文 |
簡君儒(Chun-Ru Chien)*、夏德椿(Te-Chun Hsia)、陳志毅(Chih-Yi Chen),Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis,Thoracic Cancer,2014 Nov,5(6):530-536
|
SCI論文 |
(Daniel M Geynisman)、簡君儒(Chun-Ru Chien)、(Fabrice Smieliauskas)、(Chan Shen)、(Ya-Chen Tina Shih)*,Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review,Human Vaccines & Immunotherapeutics,2014 Nov,10(11):3415-3424
|
Other論文 |
陳自諒(William Tzu-Liang Chen)、柯道維(TAO-WEI KE)、廖裕民(Yu-Min Liao)、李佳瑾(Chia-Chin Li)、簡君儒(Chun-Ru Chien)*,Optimal interval of surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: population level evidence in addition to controlled trial,Journal of Gastrointestinal Oncology,2014 Nov,6(3):38-39
|
SCI論文 |
謝淑惠(Shwn-Huey Shieh)、謝嘉容(Vivian Chia-Rong Hsieh)、劉淑惠、簡君儒(Chun-Ru Chien)、林正介(Cheng-Chieh Lin)、吳聰能(Trong-Neng Wu)*,Delayed time from first medical visit to diagnosis for breast cancer patients in Taiwan,JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,2014 Oct,113():696-703
|
SCI論文 |
夏德椿(Te-Chun Hsia)、涂智彥(Chih-Yen Tu)、陳鴻仁(Hung-Jen Chen)、陳碩爵(Shuo-Chueh Chen)、梁基安(Ji-An Liang)、陳志毅(Chih-Yi Chen)、王耀慶(Yao-Ching Wang)*、簡君儒(Chun-Ru Chien)*,A Population-based Study of Primary Chemoradiotherapy in Clinical Stage III Non-small Cell Lung Cancer: Intensity-modulated Radiotherapy Versus 3D Conformal Radiotherapy,ANTICANCER RESEARCH,2014 Sep,34():5175-5180
|
SCI論文 |
陳自諒(William Tzu-Liang Chen)、柯道維(TAO-WEI KE)、李佳瑾(CHIA-CHIN LI)、簡君儒(Chun-Ru Chien)*,Questionable role of adjuvant chemotherapy in rectal cancer patients who had reached pathological complete response after neoadjuvant concurrent chemoradiotherapy: no matter in the East or in the West,JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY,2014 Sep,140(9):1495-1496
|
SSCI論文 |
(Fabrice Smieliauskas)、簡君儒(Chun-Ru Chien)、(Chan Shen)、(Daniel M. Geynisman)、(Ya-Chen Tina Shih)*,Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review,PHARMACOECONOMICS,2014 Jul,32(7):651-680
|
SSCI論文 |
(Chan Shen)、簡君儒(Chun-Ru Chien)、(Daniel M Geynisman)、(Fabrice Smieliauskas)、(Ya-Chen T Shih)*,A review of economic impact of targeted oral anticancer medications,Expert Review of Pharmacoeconomics & Outcomes Research,2014 Feb,14(1):45-69
|
SCI論文 |
王耀慶(Yao-Ching Wang)、陳尚文(Shang-Wen Chen)、簡君儒(Chun-Ru Chien)、謝德鈞(Te-Chun Hsieh)、游浚彥(Chun-Yen Yu)、(Yu-Cheng Kuo)、楊世能(Shih-Neng Yang)、高嘉鴻(Chia-Hung Kao)*、梁基安(Ji-An Liang)*,Radiotherapy for Esophageal Cancer Using Simultaneous Integrated Boost Techniques: Dosimetric Comparison of Helical TomoTherapy, Volumetric-modulated Arc Therapy (RapidArc) and Dynamic Intensity-Modulated Radiotherapy.,TECHNOLOGY IN CANCER RESEARCH & TREATMENT,2013 Dec,12(6):485-491
|
SCI論文 |
簡君儒(Chun-Ru Chien)、梁基安(Ji-An Liang)、(Jin-Hua Chen)、(Hsiao-Nin Wang)、林則成、陳志毅(Chih-Yi Chen)、(Pin-Hui Wang)、高嘉鴻(Chia-Hung Kao)*、(Jun-Jun Yeh)*,[18F]Fluorodeoxyglucose-positron emission tomography screening for lung cancer: a systematic review and meta-analysis,CANCER IMAGING,2013 Dec,13(4):458-465
|
SCI論文 |
林精湛(Ching-Chan Lin)、陳姿婷(Tzu-Ting Chen)、林振源(Chen-Yuan Lin)、謝清昀(Ching-Yun Hsieh)*、林柏翰(Po-Han Lin)、簡君儒(Chun-Ru Chien)、邱昌芳(Chang-Fang Chiu)、葉士芃(Su-Peng Yeh),The prognostic analysis of adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma,Future Oncology,2013 Sep,9(10):1-8
|
SCI論文 |
(Yu-Yu Lu)、陳錦華(Chen Jin-Hua)、簡君儒(Chun-Ru Chien)、陳自諒(William Tzu-Liang Chen)、(Shih-Chuan Tsa)、(Wan-Yu Lin)*、高嘉鴻(Chia-Hung Kao)*,Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.,INTERNATIONAL JOURNAL OF COLORECTAL DISEASE,2013 Aug,28(8):1039-1047
|
SCI論文 |
夏德椿(Te-Chun Hsia)、涂智彥(Chih-Yen Tu)、陳鴻仁(Hung-Jen Chen)、簡君儒(Chun-Ru Chien)*,Effectiveness of Intensity-Modulated Radiotherapy for Lung Cancer,CLINICAL ONCOLOGY,2013 Jul,25(7):447-448
|
SCI論文 |
方信元(Hsin-Yuan Fang)、陳志毅(Chih-Yi Chen)、王耀慶(Yao-Ching Wang)、王品惠、謝淑惠(Shwn-Huey Shieh)、簡君儒(Chun-Ru Chien)*,Consistently lower narcotics consumption after video-assisted thoracoscopic surgery for early stage non-small cell lung cancer when compared to open surgery: a one-year follow-up study,EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY,2013 Apr,43():783-786
|
SCI論文 |
簡君儒(Chun-Ru Chien)、(Shih YC)*,Use of Personalized Decision Analysis in Decision Making for Palliative vs. Surgical Management of the Oldest-Old Patients With Localized Skin Cancer in a Culturally Sensitive Environment: A Case Study of a 96-Year-Old Male Taiwanese Patient,JOURNAL OF PAIN AND SYMPTOM MANAGEMENT,2013 Apr,45(4):792-797
|
SCI論文 |
陳尚文(Shang-Wen Chen)*、梁基安(Ji-An Liang)、洪耀欽(Yao-Ching Hung)、葉聯舜(Lian-Shung Yeh)、張維君(Wei-Chun Chang)、林武周(Wu-Chou Lin)、簡君儒(Chun-Ru Chien),Does initial 45Gy of pelvic intensity-modulated radiotherapy reduce late complications in patients with locally advanced cervical cancer? A cohort control study using definitive chemoradiotherapy with high-dose rate brachytherapy,Radiology and Oncology,2013 Mar,47(2):176-184
|
SCI論文 |
黃宗祺(Tzungchi Huang)*、(Chien-Yi Hsiao)、簡君儒(Chun-Ru Chien)、梁基安(Ji-An Liang)、施子卿(TZU-CHING SHIH)、(Geoffrey G. Zhang),IMRT treatment plans and functional planning with functional lung imaging from 4D-CT for thoracic cancer patients,Radiation Oncology,2013 Jan,8(3):1-10
|
SCI論文 |
簡君儒(Chun-Ru Chien)、蘇珊玉(Shan-Yu Su)、(Lorenzo Cohen)、林香汶(Margaret Hsiang-Wen Lin)、(Richard Tsong Lee)、(Ya-Chen Tina Shih)*,Use of Chinese Medicine Among Survivors of Nasopharyngeal Carcinoma in Taiwan: A Population-Based Study,INTEGRATIVE CANCER THERAPIES,2012 Sep,11(3):221-231
|
SCI論文 |
蔡馨慧(TSAI HSINHUI)、林香汶(Margaret Hsiang-Wen Lin)*、簡君儒(Chun-Ru Chien)、李采娟(Tsai-Chung Li),Concurrent use of antiplatelets, anticoagulants, or digoxin with Chinese medications: a population-based cohort study,EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,2012 Aug,():
|
SCI論文 |
王耀慶(Yao-Ching Wang)、謝德鈞(Te-Chun Hsieh)、游浚彥(Chun-Yen Yu)、顏國揚(Kuo-Yang Yen)、陳尚文(Shang-Wen Chen)、楊世能(Shih-Neng Yang)、簡君儒(Chun-Ru Chien)、許世明(Shih-Ming Hsu)、潘亭壽(Tinsu Pan)、高嘉鴻(Chia-Hung Kao)*、梁基安(Ji-An Liang)*,The Clinical Application of 4D 18F-FDG PET/CT on Gross Tumor Volume Delineation for Radiotherapy Planning in Esophageal Squamous Cell Cancer,JOURNAL OF RADIATION RESEARCH,2012 Jun,53(6):594-600
|
SCI論文 |
林精湛(Ching-Chan Lin)、夏德椿(Te-Chun Hsia)、簡君儒(Chun-Ru Chien)*,3rd line Erlotinib for lung cancer in Asia may be as cost-effective as in the Western woeld,LUNG CANCER,2012 Mar,():
|
SCI論文 |
簡君儒(Chun-Ru Chien)、(I-WEN PAN)、(YI-WEN TSAI)、(TERESSA TSAI)、梁基安(Ji-An Liang)、(THOMAS A. BUCHHOLZ)、(YA-CHEN TINA SHIH)*,RADIATION THERAPY AFTER BREAST-CONSERVING SURGERY: DOES HOSPITAL,INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,2012 Jan,82(1):43-50
|
SCI論文 |
魯祐祐(Yu-Yu Lu)、陳錦華(Chen Jin-Hua)、(Hueisch-Jy Ding)、簡君儒(Chun-Ru Chien)、林萬鈺(LIN WAN-YU)*、高嘉鴻(Chia-Hung Kao)*,A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT,NUCLEAR MEDICINE COMMUNICATIONS,2012 ,33(11):1127-1133
|
SCI論文 |
簡君儒(Chun-Ru Chien)、林香汶(Margaret Hsiang-Wen Lin)、(Yang, C.-H)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、郭于誠(Yu-Cheng, Kuo)、陳尚文(Shang-Wen Chen)*、梁基安(Ji-An Liang)*,High case volume of radiation oncologists is associated with better survival of nasopharyngeal carcinoma patients treated with radiotherapy: a multifactorial cohort analysis,CLINICAL OTOLARYNGOLOGY,2011 Dec,36(1):558-565
|
SCI論文 |
(Shih YCT)*、簡君儒(Chun-Ru Chien)、(Xu Y)、(Pan IW)、(Smith GL)、(Buchholz TA),Economic Burden of Renal Cell Carcinoma: Part I - An Updated Review,PHARMACOECONOMICS,2011 Apr,29(4):315-329
|
SCI論文 |
(Shih YCT)*、簡君儒(Chun-Ru Chien)、(Xu Y)、(Pan IW)、(Smith GL)、(Buchholz TA),Economic Burden of Renal Cell Carcinoma: Part II- An Updated Analysis,PHARMACOECONOMICS,2011 Apr,29(4):331-341
|
SCI論文 |
高嘉鴻(Chia-Hung Kao)、謝德鈞(Te-Chun Hsieh)、游浚彥(Chun-Yen Yu)、顏國揚(Kuo-Yang Yen)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、陳尚文(Shang-Wen Chen)*,18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck Cancer: a correlation study between suitable uptake value threshold,Radiation Oncology,2010 Sep,5(76):1-8
|
SCI論文 |
簡君儒(Chun-Ru Chien)、楊仕哲(Su-Tso Yang or YANG Shi-zhe)、陳志毅(Chih-Yi Chen)、方信元(Hsin-Yuan Fang)、涂智彥(Chih-Yen Tu)、曾冠欽(Guan-Chin Teseng)、余養豪(Yang-Hao Yu)、陳鴻仁(Hung-Jen Chen)、何致德(Chih-Te Ho)、謝清昀(Ching-Yun Hsieh)、陳香霓(Shung-Ni CHen)、陳品儒(Pin-Ru Chen)、劉峻成(Juhn-Cherng Liu)、王耀慶(Yao-Ching Wang)、吳蕙樺(Hui-Hua Wu)、夏德椿(Te-Chun Hsia)*,Impact of the New Lung Cancer Staging System for a Predominantly Advanced-Disease Patient Population,Journal of Thoracic Oncology,2010 Mar,5(3):340-343
|
SCI論文 |
簡君儒(Chun-Ru Chien)、林振源(Chen-Yuan Lin)、陳志毅(Chih-Yi Chen)*,Re: Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and Age,JOURNAL OF THE NATIONAL CANCER INSTITUTE,2009 Oct,101(20):1428-1428
|
SCI論文 |
簡君儒(Chun-Ru Chien)、陳秀熙(Chen, Tony Hsiu-Hsi)*,A Bayesian model for age, period, and cohort effects on mortality trends for lung cancer, in association with gender-specific incidence and case-fatality rates,Journal of Thoracic Oncology,2009 Feb,4(2):167-171
|
SCI論文 |
簡君儒(Chun-Ru Chien)、陳尚文(Shang-Wen Chen)、陳自諒(William Tzu-Liang Chen)*,RADIATION FIELDS OF NEOADJUVANT CONCURRENT CHEMORADIOTHERAPY FOR RECTAL CANCER: IN REGARD TO YU ET AL.,INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,2009 Feb,73(2):639-639
|
SCI論文 |
(Yen Ruoh-Fang)、(Yen Ming-Fang)、(Hong Ruey-Long)、(Tzen Kai-Yuan)、簡君儒(Chun-Ru Chien)、(Chen Tony Hsiu-Hsi)*,The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma,ACADEMIC RADIOLOGY,2009 Jan,16(1):54-60
|
SCI論文 |
簡君儒(Chun-Ru Chien)、賴美淑(Mei-Shu Lai)、陳秀熙(Tony Hsiu-Hsi Chen)*,Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach,LUNG CANCER,2008 Nov,62(2):215-220
|
SCI論文 |
簡君儒(Chun-Ru Chien)、陳志毅(Chih-Yi Chen)、梁基安(Ji-An Liang)*,Re: Intensity-Modulated Radiation Therapy Dose Prescription, Recording, and Delivery: Patterns of Variability Among Institutions and Treatment Planning Systems,JOURNAL OF THE NATIONAL CANCER INSTITUTE,2008 Sep,100(17):1263-1267
|
Other論文 |
簡君儒(Chun-Ru Chien)、楊榮森(Rong-Sen Yang)*,緩解性體外放射治療,台灣醫學,2008 Jul,12(4):425-430
|
SCI論文 |
高劍虹(Gow, C.H.)、簡君儒(Chun-Ru Chien)、張逸良(Chang, Y.L)、邱月暇(Chiu, YH)、郭頌鑫(Kuo, S.H.)、施金元(Shih, J.Y.)*、張允中(Chang, Y.C.)、余忠仁(Yu, C.J.)、楊志新(Yang, C.H.)、楊泮池(Yang, P.C.),Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response,CLINICAL CANCER RESEARCH,2008 Jan,14(1):162-168
|
SCI論文 |
簡君儒(Chun-Ru Chien)、陳秀熙(Tony Hsiu-Hsi Chen)*,Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography,INTERNATIONAL JOURNAL OF CANCER,2008 Jan,122(11):2594-2599
|
SCI論文 |
簡君儒(Chun-Ru Chien)、(Chun-Ming Tsai,)、(Siew-Tzuh Tang,)、(Kuo-Piao Chung,)、(Chao-Hua Chiu,)、賴美淑(Mei-Shu Lai)*,Quality of Care for Lung Cancer in Taiwan: A Pattern of Care Based on Core Measuresin the Taiwan Cancer Database Registry,JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,2008 ,107(8):635-643
|
SCI論文 |
簡君儒(Chun-Ru Chien)、張逸良(Chang, Y.L.)、林東燦(Lin, D.T.)、楊榮森(Yang, R.S.)*,Excellent survival of pediatric dermatofibrosarcoma protuberans in Taiwanese,PEDIATRIC SURGERY INTERNATIONAL,2007 Mar,23(3):211-214
|
SCI論文 |
簡君儒(Chun-Ru Chien)、賴美淑*,Trends in the pattern of care for lung cancer and their correlation with new clinical evidence: Experiences in a university-affiliated medical center,AMERICAN JOURNAL OF MEDICAL QUALITY,2006 Dec,21(6):408-414
|
SCI論文 |
簡君儒(Chun-Ru Chien)、丁禮莉(Ding, L.L.)、謝長堯(Hsieh, C.Y.)、賴美淑(Lai, M.S.)*,Post-radiation Pap smear for Chinese patients with Cervical Cancer: a ten year follow-up,EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY,2005 Dec,16(6):619-622
|
Other論文 |
簡君儒(Chun-Ru Chien)、丁禮莉(Ding, L.L.)、鍾娜娜(Chung, N.N.)、雷德(Lui, L.T.)*,Local Regional Relapse Patterns Following Ipsilateral Postoperative Adjuvant Radiotherapy for Buccal Cancer,中華放射線技術學雜誌,2005 Feb,28(1):9-15
|
Other論文 |
簡君儒(Chun-Ru Chien)、許雅娟(Hsu, Y.C.)、王耀慶(Wang, Y.C.)、丁禮莉(Ding, L.L.)*,Clinical Risk Factors of Radiation Pneumonitis after 3D Conformal Radiotherapy for Lung Cancer,中華放射線醫學雜誌,2005 Feb,30(1):25-29
|
|
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
|
1﹒ |
大腸直腸癌游離癌基因體套組之臨床確效應用,110年度年會暨學術發表會,台大國際會議中心,2021.11.6 ~ 2021.11.6,
|
2﹒ |
Out-of-pocket cost of cancer treatement: a systematic review for literatures from Taiwan,The live Virtual ISPOR Asia Pacific 2020 conference,live,2020.9.14 ~ 2020.9.16,
|
3﹒ |
The effect of image-guided radiotherapy on cancer patients' survival,The live Virtual ISPOR Asia Pacific 2020 conference,live,2020.9.14 ~ 2020.9.16,
|
4﹒ |
Is involved field target delineation safe in spinal palliative radiotherapy?.,The 18th ECCO – 40th ESMO European Cancer Congress,Messe Wien Exhibition & Congress Center, Vienna, Austria,2015.9.25 ~ 2015.9.29,
|
5﹒ |
,The 3rd Japan-Taiwan Radiation Oncology Symposium,yamanashi,2015.6.27 ~ 2015.6.28,Preliminary Results of Neoadjuvant CCRT in Locally Advanced Rectal Cancer in CMUH
|
6﹒ |
TREATMENT OUTCOMES OF NEOADJUVANT CCRT IN PATIENTSWITH LOCALLY ADVANCED RECTAL CANCER,2015 The 20th Taiwan Joint Cancer Conference,Taipei, Taiwan,2015.5.2 ~ 2015.5.3,
|
7﹒ |
Cancer incidence and survival among Adolescent & Young Adults in Taiwan,Global Academic Programs 2015 Conference,Main Building, Floor 11 Hickey Auditorium (R11.1400) 1515 Holcombe Blvd. Houston, Texas, USA,2015.4.14 ~ 2015.4.16,
|
8﹒ |
SABR for lung cancer : preliminary experiences in CMUH,6th Varian Taiwan Users Meeting 2014,台中金典酒店,2014.10.18 ~ 2014.10.19,
|
9﹒ |
SABR for Lung Cancer: Preliminary Experiences in CMUH: An Updated Report,The 2nd Taiwan-Japan Conference on the High Precision Radiation Therapy,台北榮民總醫院 致德樓 第三會議室,2014.7.19 ~ 2014.7.20,
|
10﹒ |
To evaluate the efficacy of re-irradiation to patients with recurent or residual esophageal cancer after CCRT or RT alone-CMUH experience,第十八屆台灣癌症聯合學術年會,台大醫院國際會議中心,2013.7.13 ~ 2013.7.14,
|
11﹒ |
Diagnostic Performance of Selective Positron Emission Tomography for Lung Cancer Computed Tomography Screening: a Meta-Analysis, 第十六屆ECCO(European CanCer Organisation)年會,Stockholm, Sweden,2011.9.24 ~ 2011.9.27,
|
12﹒ |
台灣老年人用藥品項趨勢探討-健保資料庫分析,社團法人臺灣臨床藥學會100年度第12屆第2次會員代表大會暨學術研討會,中國醫藥大學,2011.9.25 ~ 2011.9.25,
|
13﹒ |
Concurrent Use of High Risk Western Medications with Traditional Chinese Medicine: One Year Population-Based Study in Taiwn,27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management,Chicago, Illinois, USA,2011.8.14 ~ 2011.8.17,
|
14﹒ |
The Number of Prescribed Medication Patterns among the Elderly in Different Patient Populations in Taiwan,27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management,Chicago, Illinois, USA,2011.8.14 ~ 2011.8.17,
|
15﹒ |
POSITRON EMISSION TOMOGRAPHY SCREENING FOR LUNG CANCER: A SYSTEMATIC REVIEW,16th ISPOR (International Society for Pharmacoeconomics and Outcomes Research) 年會,Baltimore, USA,2011.5.21 ~ 2011.5.25,
|
16﹒ |
Preliminary treatment outcome of intensity modulated radiotherapy with or without chemotherapy for nasopharyngeal carcinoma,第十四屆台灣癌症聯合醫學會暨第八屆海峽兩岸腫瘤學術會議,國防醫學院3F,2009.5.2 ~ 2009.5.3,
|
17﹒ |
Esophageal cancer in Patients with Head and neck cancer:clinical expirience in one institue,第14屆台灣癌症聯合學術年會,國防醫學院,2009.5.2 ~ 2009.5.3,
|
18﹒ |
肺癌病人接受根治性胸腔放療之預後,中華民國放射線醫學會第二十六屆第二次會員大會暨第五十七次學術研討會,台南大億麗緻酒店,2008.3.29 ~ 2008.3.30,
|
19﹒ |
針對胸部腫瘤在使用自主性呼吸控制設備固定下劑量的評估,中華民國放射線醫學會第二十六屆第二次會員大會暨第五十七次學術研討會,台南大億麗緻酒店,2008.3.29 ~ 2008.3.30,
|
|
專書/Books (作者,書名,出版商,出版日期)
|
1﹒ |
簡君儒(Chun-Ru Chien)、楊榮森,臨床傷口醫學--第十六章 放射治療傷口,力大圖書,2010.12
|
|
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
|
1﹒ |
個別型,NSTC 112-2314-B-039-048,簡君儒(Chien, Chun-Ru),梁基安(Ji-An Liang),國科會,骨盆放射治療於台灣直腸癌的效益及成本,$1039000,2023.8.1 ~ 2024.7.31
|
2﹒ |
個別型,NSTC 112-2314-B-039-061,簡君儒(Chien, Chun-Ru),梁基安(Ji-An Liang),國科會,放射治療於接受第一代或第二代標靶治療的臨床IIIB或IIIC期具表皮生長因子受體突變肺腺癌病人:成本與有效性之評估,$1160000,2023.8.1 ~ 2024.7.31
|
3﹒ |
個別型,DMR-113-046,簡君儒(Chien, Chun-Ru),梁基安(Ji-An Liang),附醫院內計畫,呼吸監控技術於台灣局部期別的肺癌病人接受根治性放射治療的效益與成本效益,$200000,2023.8.1 ~ 2024.7.31
|
4﹒ |
個別型,CMUHCH-DMR-111-009,郭于誠(Yu-Cheng Kuo),簡君儒(Chien, Chun-Ru)、梁基安(Liang, Ji-An)、周思賢(Szu-Hsien Chou),附醫院內計畫,直腸癌前導性化放療之放療劑量效應研究,$420000,2021.10.1 ~ 2022.9.30
|
5﹒ |
個別型,CMUHCH-DMR-110-002,簡君儒(Chun-Ru Chien),附醫院內計畫,影像導引放射治療在台灣的成本與效益,$420000,2020.12.1 ~ 2021.9.30
|
6﹒ |
個別型,CMUHCH-DMR-110-015,簡君儒(Chun-Ru Chien),李博彰(LEE PO-CHANG)、梁基安(Ji-An Liang)、周思賢(Szu-Hsien Chou),附醫院內計畫,影像導引放射治療在台灣的成本與效益,$385000,2020.11.1 ~ 2021.10.31
|
7﹒ |
個別型,CMU109-MF-40,林香汶(Hsiang-Wen Lin),林志學(Chih-Hsueh Lin)、葉士芃(Shih-Peng Yeh)、簡君儒(Chun-Ru Chien)、葉子裴(Tzu-Pei Yeh)、李采娟(Tsai-Chung Li)、夏德椿(Te-Chun Hsia)、李佳霙(Chia-Ing Li)、謝右文(Yow-Wen Hsieh)、林振源(Lin, Chen-Yuan)、陳育傑(Yu-Chieh Chen)、劉良智(Liang-Chih Liu)、郭錦輯(Kuo, Chin-Chi),國科會,於臨床執業中納入病人自述成效測量-癌症病人使用新科技藥品為例,$300000,2020.9.8 ~ 2021.7.31
|
8﹒ |
個別型,MOST 109-2320-B-039-023,林香汶(Hsiang-Wen Lin),林志學(Chih-Hsueh Lin)、葉士芃(Shih-Peng Yeh)、簡君儒(Chun-Ru Chien)、葉子裴(Tzu-Pei Yeh)、李采娟(Tsai-Chung Li)、夏德椿(Te-Chun Hsia)、李佳霙(Chia-Ing Li)、謝右文(Yow-Wen Hsieh)、林振源(Lin, Chen-Yuan)、陳育傑(Yu-Chieh Chen)、劉良智(Liang-Chih Liu)、郭錦輯(Kuo, Chin-Chi),國科會,於臨床執業中納入病人自述成效測量-癌症病人使用新科技藥品為例,$1300000,2020.8.1 ~ 2021.7.31
|
9﹒ |
個別型,MOST 109-2314-B-039-014,簡君儒(Chun-Ru Chien),梁基安(Ji-An Liang),國科會,影像導引放射治療在台灣的成本與效益,$840000,2020.8.1 ~ 2021.7.31
|
10﹒ |
個別型,CMUHCH-DMR-109-001,周思賢(Szu-Hsien Chou),簡君儒(Chun-Ru Chien)、阮春榮(JUAN CHUN-JUNG)、李雅惠(LI YA-HUI),附醫院內計畫,影像導引放射治療對癌症病人存活的影響,$85000,2020.3.1 ~ 2021.2.28
|
11﹒ |
個別型,CMUHCH-DMR-109-015,簡君儒(Chun-Ru Chien),梁基安(Ji-An Liang)、陳冠亨(Guang-Heng Chen),附醫院內計畫,影像導引放射治療在台灣的成本與效益,$424000,2020.3.1 ~ 2021.2.28
|
12﹒ |
個別型,A1051222-107,趙坤山(Kun-San Chao),邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(Tzu-Liang Chen)、柯道維(Tao-Wei Ke)、王輝明(Hwei-Ming Wang)、陳宏彰(Hung-Chang Chen)、黃郁純(Yu-Chuen Huang)、花俊宏(Chun-Hung Hua)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、吳錫金(Hsi-Chin Wu)、黃志平(Chi-Ping Huang)、蔡宗欣(Tzong-Shin Tzai)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、吳建廷(Chen-Teng Wu)、劉良智(Liang-Chih Liu)、吳曜充(Yao-Chung Wu)、陳芝蓉(Chih-Jung Chen)、鄭書(Yu-Shu Cheng)、方信元(Hsin-Yuan Fang)、夏德椿(Te-Chun Hsia)、李嘉翔(Chia-Hsiang Li)、陳鴻仁(Hung-Jen Chen)、劉秋松(Chiu-Shong Liu)、陳毓隆(Yu-Lung Chen)、王中儀(JONG-YI WANG),衛福部,全方位癌症照護醫病共享決策輔助工具介入及其效益評估(106-107年) 107年後續擴充,$1803511,2018.10.5 ~ 2019.10.4
|
13﹒ |
個別型,MOST 107-2314-B-039-026-,簡君儒(Chun-Ru Chien),夏德椿(Te-Chun Hsia)、梁基安(Ji-An Liang),國科會,放射治療與標靶治療於體能良好之臨床IIIB期具表皮生長因子受體突變的肺腺癌病人:成本與有效性之評估,$930000,2018.8.1 ~ 2019.7.31
|
14﹒ |
國家型,A1051222,趙坤山(Kun-San Chao),邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(William Tzu-Liang Chen)、柯道維(TAO-WEI KE)、花俊宏(Chun-Hung Hua)、張兆祥(Chang,Chao-Hsiang)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、劉良智(Liu, Liang-Chih)、吳曜充(Yao-Chung Wu)、方信元(Hsin-Yuan Fang)、夏德椿(Te-Chun Hsia)、李嘉翔(Chia-Hsiang Li)、黃郁純(YU-CHUEN HUANG)、王中儀(JONG-YI WANG),衛福部,全方位癌症照護醫病共享決策輔助工具介入及其效益評估(106-107年),$1241289,2017.2.16 ~ 2018.2.15
|
15﹒ |
國家型,A1051121,周德陽(Der-Yang Cho),趙坤山(Kun-San Chao)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、彭成元(Cheng-Yuan Peng)、夏德椿(Te-Chun Hsia)、陳自諒(William Tzu-Liang Chen)、洪耀欽(Yao-Ching Hung)、方信元(Hsin-Yuan Fang)、楊美都(Mei-Due Yang)、葉士芃(Su-Peng Yeh)、劉良智(Liu, Liang-Chih)、張兆祥(Chang,Chao-Hsiang)、柯道維(TAO-WEI KE)、葉聯舜(Lian-Shung Yeh)、梁基安(Ji-An Liang)、林文元(Wen-Yuan Lin)、王約翰(John Wang)、謝右文(Yow-Wen Hsieh)、蔡麗雲(Li-Yun Tsai)、謝淑惠(Shwn-Huey Shieh)、廖惠娟(Hui-Chuan Liao)、孟乃欣(Nai-Hsin Meng)、花俊宏(Chun-Hung Hua)、楊啟瑞(Che-Rei Yang)、徐華穗(Hua-Shai Hsu)、詹佳穎(Chia-Ing Jan)、蔡伯邦(Po-Pang Tsai)、林昭君(Chao-Chun Lin)、吳博倫(Po-Lun Wu)、謝清昀(Ching-Yun Hsieh)、簡君儒(Chun-Ru Chien)、楊世能(Shih-Neng Yang)、白禮源(Li-Yuan Bai),衛福部,106醫院癌症診療品質精進計畫,$11540000,2017.1.1 ~ 2017.12.31
|
16﹒ |
臨床試驗與研究計畫,CMUH105-REC2-132,林振源(Chen-Yuan Lin),邱昌芳(Chiu, Chang-Fang)、簡君儒(Chien, Chun-Ru)、王耀慶(Wang, Yao-Ching)、方信元(Fang, Hsin-Yuan)、林昱森(Yu-Sen Lin)、連銘渝(Ming-Yu Lein),附醫廠商計畫,一項隨機、多中心、雙盲,在食道癌或胃食道交接處癌症已切除的受試者中,比較nivolumab輔助療法與安慰劑的第三期試驗,$2183703,2017.1.1 ~ 2017.12.31
|
17﹒ |
個別型,DMR-106-059,簡君儒(Chun-Ru Chien),梁基安(Ji-An Liang),附醫院內計畫,放射治療新技術的使用、成本與效益 : 以影像導航放射治療為例,$300000,2016.8.1 ~ 2017.7.31
|
18﹒ |
個別型,A1041016,周德陽(Der-Yang Cho),趙坤山(Kun-San Chao)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、彭成元(Cheng-Yuan Peng)、夏德椿(Te-Chun Hsia)、陳自諒(William Tzu-Liang Chen)、洪耀欽(Yao-Ching Hung)、楊美都(Mei-Due Yang)、葉士芃(Su-Peng Yeh)、劉良智(Liu, Liang-Chih)、楊啟瑞(Che-Rei Yang)、柯道維(TAO-WEI KE)、葉聯舜(Lian-Shung Yeh)、梁基安(Ji-An Liang)、詹佳穎(Chia-Ing Jan)、林文元(Wen-Yuan Lin)、林昭君(Chao-Chun Lin)、蔡伯邦(Po-Pang Tsai)、花俊宏(Chun-Hung Hua)、吳博倫(Po-Lun Wu)、謝清昀(Ching-Yun Hsieh)、簡君儒(Chun-Ru Chien)、楊世能(Shih-Neng Yang)、白禮源(Li-Yuan Bai)、謝右文(Yow-Wen Hsieh)、謝淑惠(Shwn-Huey Shieh)、蔡麗雲(Li-Yun Tsai)、廖惠娟(Hui-Chuan Liao),衛福部,105年度醫院癌症診療品質提升計畫-分項2,$11480000,2016.1.1 ~ 2016.12.31
|
19﹒ |
個別型,MOST 104-2314-B-039-041,簡君儒(Chun-Ru Chien),梁基安(Ji-An Liang),國科會,放射治療新技術的使用、成本、與效益: 以影像導航放射治療為例,$702000,2015.8.1 ~ 2016.7.31
|
20﹒ |
個別型,DMR-105-046,簡君儒(Chun-Ru Chien),夏德椿(Te-Chun Hsia)、方信元(Hsin-Yuan Fang)、梁基安(Ji-An Liang)、涂智彥(Chih-Yen Tu)、楊仕哲(Su-Tso Yang or YANG Shi-zhe),附醫院內計畫,癌症治療的效用與成本效益:台灣經驗, 以身體立體定位放射治療為例,$200000,2015.8.1 ~ 2016.7.31
|
21﹒ |
整合型(召集人、總主持人),A1031024,周德陽(Der-Yang Cho),趙坤山(Kun-San Chao)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、彭成元(Cheng-Yuan Peng)、夏德椿(Te-Chun Hsia)、陳自諒(William Tzu-Liang Chen)、洪耀欽(Yao-Ching Hung)、方信元(Hsin-Yuan Fang)、楊美都(Mei-Due Yang)、葉士芃(Su-Peng Yeh)、劉良智(Liu, Liang-Chih)、柯道維(TAO-WEI KE)、葉聯舜(Lian-Shung Yeh)、梁基安(Ji-An Liang)、林智一(Tze-Yi Lin)、林文元(Wen-Yuan Lin)、蔡伯邦(Po-Pang Tsai)、謝清昀(Ching-Yun Hsieh)、花俊宏(Chun-Hung Hua)、楊世能(Shih-Neng Yang)、簡君儒(Chun-Ru Chien)、白禮源(Li-Yuan Bai)、謝右文(Yow-Wen Hsieh)、蔡麗雲(Li-Yun Tsai)、廖惠娟(Hui-Chuan Liao),衛福部,104年度醫院癌症診療品質提升計畫,$13860000,2015.1.1 ~ 2015.12.31
|
22﹒ |
個別型,102-2410-H-002-058-MY2,蕭斐元,簡君儒(Chun-Ru Chien),國科會,運用臨床實證評估全民健康保險藥品給付制度:以顆粒性白血球生長刺激素於癌症病患之使用為例,$532000,2014.8.1 ~ 2015.7.31
|
23﹒ |
整合型(召集人、總主持人),A1021236,周德陽(Der-Yang Cho),蔡銘修(Ming-Hsui Tsai)、蔡伯邦(Po-Pang Tsai)、彭成元(Cheng-Yuan Peng)、邱昌芳(Chang-Fang Chiu)、謝清昀(Ching-Yun Hsieh)、謝右文(Yow-Wen Hsieh)、葉士芃(Su-Peng Yeh)、花俊宏(Chun-Hung Hua)、楊世能(Shih-Neng Yang)、夏德椿(Te-Chun Hsia)、陳自諒(William Tzu-Liang Chen)、許玲女(Ling-Nu Hsu)、葉聯舜(Lian-Shung Yeh)、林維卿(Wei-Ching Lin)、劉秋松(Chiu-Shong Liu)、梁基安(Ji-An Liang)、陳志毅(Chih-Yi Chen)、洪耀欽(Yao-Ching Hung)、吳錫金(Wu,Hsi-Chin)、謝淑惠(Shwn-Huey Shieh)、柯道維(TAO-WEI KE)、方信元(Hsin-Yuan Fang)、楊美都(Mei-Due Yang)、林文元(Wen-Yuan Lin)、白禮源(Li-Yuan Bai)、范淑貞(Shu-Chen Fan)、劉良智(Liu, Liang-Chih)、簡君儒(Chun-Ru Chien)、林智一(Tze-Yi Lin)、廖惠娟(Hui-Chuan Liao),衛福部,103年醫院癌症診療品質提升計畫,$14400000,2014.1.22 ~ 2014.12.31
|
24﹒ |
個別型,DMR-103-043,簡君儒(Chun-Ru Chien),梁基安(Ji-An Liang),附醫院內計畫,放射治療新技術的使用、成本、與效益: 以影像導航放射治療為例,$250000,2013.8.1 ~ 2014.7.31
|
25﹒ |
個別型,102-2410-H-002 -058 -MY2,蕭斐元,簡君儒(Chun-Ru Chien),國科會,運用臨床實證評估全民健康保險藥品給付制度:以顆粒性白血球生長刺激素於癌症病患之使 用為例,$514000,2013.8.1 ~ 2014.7.31
|
26﹒ |
整合型(召集人、總主持人),102CANCER,周德陽(Der-Yang Cho),陳志毅(Chih-Yi Chen)、邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、彭成元(Cheng-Yuan Peng)、蔡伯邦(Po-Pang Tsai)、謝清昀(Ching-Yun Hsieh)、謝右文(Yow-Wen Hsieh)、葉士芃(Su-Peng Yeh)、花俊宏(Chun-Hung Hua)、楊世能(Shih-Neng Yang)、夏德椿(Te-Chun Hsia)、陳自諒(William Tzu-Liang Chen)、許玲女(Ling-Nu Hsu)、葉聯舜(Lian-Shung Yeh)、何永仁(Yung-Jen Ho)、劉秋松(Chiu-Shong Liu)、梁基安(Ji-An Liang)、洪耀欽(Yao-Ching Hung)、吳錫金(Wu,Hsi-Chin)、謝淑惠(Shwn-Huey Shieh)、柯道維(TAO-WEI KE)、方信元(Hsin-Yuan Fang)、楊美都(Mei-Due Yang)、林文元(Wen-Yuan Lin)、白禮源(Li-Yuan Bai)、葉名焮(Ming-Hsin, Alex, Yeh)、簡君儒(Chun-Ru Chien)、林智一(Tze-Yi Lin)、范淑貞(Shu-Chen Fan),衛福部,102年醫院癌症醫療品質提升計畫,$13132010,2013.1.1 ~ 2013.12.31
|
27﹒ |
個別型,NSC 98-2314-B-039-014-MY3,簡君儒(Chun-Ru Chien),顏若芳、陳秀熙、劉峻成(Juhn-Cherng Liu)、林香汶(Margaret Hsiang-Wen Lin),國科會,肺癌篩檢之有效性與醫療經濟評估,$471000,2011.8.1 ~ 2012.7.31
|
28﹒ |
個別型,NSC 98-2314-B-039-014-MY3,簡君儒(Chun-Ru Chien),顏若芳、陳秀熙、劉峻成(Juhn-Cherng Liu)、林香汶(Margaret Hsiang-Wen Lin),國科會,肺癌篩檢之有效性與醫療經濟評估,$331000,2010.8.1 ~ 2011.7.31
|
29﹒ |
個別型,NSC 98-2314-B-039-014-MY3,簡君儒(Chun-Ru Chien),顏若芳、陳秀熙、劉峻成(Juhn-Cherng Liu)、林香汶(Margaret Hsiang-Wen Lin),國科會,肺癌篩檢之有效性與醫療經濟評估,$331000,2009.8.1 ~ 2010.7.31
|
30﹒ |
個別型,DMR-99-140,林香汶(Margaret Hsiang-Wen Lin),簡君儒(Chun-Ru Chien)、李佳霙(Chia-Ing Li)、林振源(Chen-Yuan Lin)、林志學(Chih-Hsueh Lin)、林玟玲(Wen-Ling Lin),附醫院內計畫,老人病患用藥成效研究-用藥型態分析,$100000,2009.8.1 ~ 2010.7.31
|
31﹒ |
個別型,DMR-98-009,林振源(Chen-Yuan Lin),林香汶(Margaret Hsiang-Wen Lin)、葉士芃(Shih-Peng Yeh)、陳品儒(Pin-Ru Chen)、簡君儒(Chun-Ru Chien)、葉子裴(Tzu-Pei Yeh)、吳淑惠(Swu-Hwa Wu),附醫院內計畫,食道癌病患之疾病負擔前導評估研究,$300000,2009.1.7 ~ 2009.12.31
|
|